BioSpace News Archive

ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS ® System.

Cyclo Therapeutics, Inc. today announced that Lise Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will present at the World Orphan Drug Congress USA 2022 being held July 11-13, 2022.

Halo Labs , a leading life science instrumentation company announced it has raised $6M in series C financing.

Novavax, Inc. (Nasdaq: NVAX), today announced an agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, to secure an initial 3.2 million doses of Novavax’ COVID-19 vaccine (NVX-CoV2373) should it receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) and a recommendation from the Centers for Disease Control and Prevention (CDC).

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has entered into a definitive agreement under which Vertex will acquire ViaCyte, a privately held biotechnology company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for type 1 diabetes (T1D), for $320 million in cash.

Notice of Allowance of Patent Application for Use of Topical B-Raf Inhibitors for the Treatment, Prevention or Alleviation of Radiation Dermatitis, Strengthens Intellectual Property Position Until 2041.

Lunit has announced the presentation of five abstracts featuring its AI solutions for chest and breast radiology at the European Congress of Radiology (ECR) Meeting 2022, held in Vienna, Austria, July 13th through 17th.

MindMaze, a global pioneer in the development of neurotechnology, today confirms a new partnership with Alfa Romeo F1 Team ORLEN.

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”) introduces today the “Liby™" System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure.

The Lung Cancer Research Foundation is pleased to announce the appointment of a select group of its Scientific Advisory Board members to a newly-created Scientific Executive Committee.